Clinical Trials Logo

Clinical Trial Summary

The immune response to Helicobacter pylori (Hp) importantly determines the pathogenesis of infection as well as the success of antibiotic eradication of the bacteria. The investigators want to demonstrate the importance of cathepsin X (CTSX), a cysteine protease, for the Hp eradication success. The diversity of the innate immune response to H. pylori antigens leading to either successful eradication of the infection or maintenance of chronic inflammation is connected to CTSX. The aim of this study is to determine whether H. pylori suppresses the CTSX expression and cytokine secretion in macrophage cell line THP-1 in the individuals that are not capable of eradicating the infection, opposite to H pylori in patients with successful H pylori eradication . The investigators also investigate the possibility whether strain-dependent differences in H. pylori lipopolysaccharide (LPS) influence the CTSX expression and cytokine secretion.


Clinical Trial Description

n/a


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Infection
  • Persistence of Infection With Helicobacter Pylori

NCT number NCT01137942
Study type Observational
Source University Medical Centre Ljubljana
Contact Alojz Ihan, MD, PhD
Phone 0038615437493
Email alojz.ihan@mf.uni-lj.si
Status Recruiting
Phase N/A
Start date November 2008
Completion date July 2010